Latest Conference

Existing maternal cardiac risk models showed poor prediction of neonatal complications in pregnancies complicated by congenital heart disease.

Don Arnold, MD, MPH, highlights how a nurse-driven guideline reduced time to phototherapy in neonatal jaundice care.

Raising pediatric flu vaccination to 70% could significantly reduce outpatient visits, hospitalizations, and deaths, easing strain on US systems.

Pilot study finds maternal dairy intake associated with lower levels of select human milk lipids, with unclear implications for infant health.

Data presented at PAS 2026 show that specific neighborhood factors—not overall scores—drive asthma outcomes, pointing to targeted interventions for reducing ED visits.

Autism diagnoses by primary care providers vary widely by region and state, highlighting disparities in access to specialty care.

Maternal RSV vaccination and nirsevimab were linked to lower infection rates and reduced severity in infants younger than 6 months.

Large trial finds balanced fluids and saline yield similar outcomes in pediatric septic shock, reinforcing flexible resuscitation practices.

MMR coverage remained below herd immunity 20 months after an Ohio outbreak, with minimal gains and persistent disparities in children.

Brian Schroer, MD, highlights recent data exploring the origins of EoE inflammation and the efficacy and limitations of recent biologic treatments.

Findings from a pilot randomized trial of a multifaceted pediatric obesity care model found strong family engagement and highlighted the importance of psychosocial support in treatment.

Experts discuss how specialty pharmacy partnerships dramatically improved GLP-1 access, adherence, and workflow efficiency for teens with obesity.

"What is the possibility for your individual child that you're taking care of as a patient, as a family member advocate?" said Oliva Kim-McManus, MD.

In this interview from the 2025 Child Neurology Society meeting, Olivia Kim-McManus explains how far the gene therapy and genetic testing space has come related to pediatric neurology.

Sub-analysis of ADORING trials shows VTAMA cream improved skin clearance, symptoms, and patient-reported outcomes in children aged 2-17.

Valeria C. Cohran, MD, emphasized the importance of close collaboration between intestinal rehab programs and general pediatricians to optimize care for children with intestinal failure.

Older age, longer remaining intestine, and presence of an ileocecal valve were linked with a greater likelihood of achieving sustained enteral autonomy in children with short bowel syndrome-associated intestinal failure.

Dupilumab maintained histologic and endoscopic improvements across all pediatric age groups with EoE, according to Joshua Wechsler, MD.